Key actor in the Algerian pharmaceutical ecosystem

Propharmal, a key player within the Algerian pharmaceutical environment, belongs to CFAO Healthcare Group, an affiliate of the TOYOTA TSUSHO CORPORATION group.

For 25 years, Propharmal has been the favorite partner of international pharmaceutical companies seeking to expand their activities in the Algerian market.

+ 0

Years

D'expérience

Propharmal in
a few figures

At Propharmal, quality, accessibility, and innovation are at the core of our commitment to the pharmaceutical industry.

0

Billions DZD

Investments

0

Square meters

Factory area

0

Collaborators

0

Launches

Per year

0

Laboratories

Partners

0

Millions

Produced units

0

Millions

Production capacity

Value added services

Propharmal provides high-value services all along the end-to-end flow, covering production, import, marketing, and promotion.

Thanks to several partnerships in OTC and food supplement ranges, Propharmal’s production unit has grown year after year. Furthermore, the new effervescent line launched in 2022 establishes Propharmal as the leader in its category on the market.

The dynamic launch of a dozen new products in full development in 2023 and 2024 will allow Propharmal to control the full manufacturing process and guarantee patients a diversified offer of quality and best-priced medicine.

Besides, the industrial capacity will create export opportunities to African countries and will reinforce the national pharmaceutical industry strategy.

Strategic growth and global impact

An exceptional team

Last but not least, everything is possible thanks to the 220 professional, highly qualified, exemplary, and patient-oriented employees.